Find a Doctor or Practice Location

Autoimmune skin disease
Cutaneous Lupus Erythematosus
Dermatomyositis
Pemphigus vulgaris

Medical School: Johns Hopkins University School of Medicine
Residency: Northwestern Medical Center
Residency: New York University Medical Center

American Academy of Dermatology Program for Dermatology for the 21st Century , National American Academy of Dermatology, member, National American Board of Dermatology , National American College of Physicians, American College of Rheumatology, Canadian Dermatology Society, National Committee on Government and Public Relations. Society of Investigative Dermatology (2002-), Data Safety Monitoring Board for High Dose Immunoblative Cytoxan for Lupus Erythematosus (Michelle Petri, Johns Hopkins), 1999-present, Dermatology Field Advisory Committee,(reports to Central Office, VA), National Dermatology Foundation, Dermatology Study group Co-Chair (1999) National Association of V.A. Dermatologists, Secretary- , European Society of Cutaneous Lupus Erythematosus, International FOCIS Abstract Review Committee, National Leaders Society Campaign for the Dermatology Foundation, National Lupus Foundation of America, National Lupus Foundation of Delaware Valley (1998-), Local Lupus Research Institute, Local Medical Advisory Board, Dermatomyositis support group, Arthritis Foundation (Pennsylvania), 2002-, Medical Advisory Board, International Inflammatory Myositis Foundation, International Medical Advisory Board, National Pemphigus Foundation (1997-), National Medical Advisory Board, Scleroderma Foundation, 2002-, National Medical Dermatology Society , Myositis Criteria Study, International National Association of Rheumatologic Dermatology Society, National National Association of VA Dermatologists, National NIH Autoimmune Centers of Excellence, National NIH Meeting on Pemphigus, National NIH/NIAMS Study Section (AMS), National Pennsylvania Academy of Dermatology, Philadelphia College of Physicians, Philadelphia Dermatology Society, Local Rheumatologic Dermatology Society, National Skin Rheumatism and Autoimmunity, International Society of Investigative Dermatology, National Society of Investigative Dermatology, National Society of Investigative Dermatology, National Symposium on Scoring Systems in Dermatology, World Congress of Dermatology, International Task Force on Government Medicine, American Academy of Dermatology , National Task Force on Internal Medicine, American Academy of Dermatology, National Workforce Retreat, National World Congress of Dermatology, International

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Description of Research Expertise:

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Selected Publications:

George M, Kreider M, Shah R, Miller Jr W, Merkel PA, Werth VP: Abnormal Pulmonary Function Tests, Interstitial Lung Disease, and Lung Function Decline in Patients with Classic and Clinically Amyopathic Dermatomyositis Br J Dermatol 176 (262-264): 2017.

van Vollenhoven R., …Werth VP: …Remission in SLE, consensus findings from a large international task force on definitions of remission in SLE (DORIS) Ann Rheum Dis 76 (554-561): 2017.

Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S: Anifrolumab, an Anti-Interferon-Alpha Receptor Monoclonal Antibody, in Moderate to Severe Systemic Lupus Erythematosus Arthritis & Rheumatol 69 (376-386): 2017.

Ang CC, Anyanwu C, Robinson E, Okawa J, Fujimoto M, Hamaguchi Y, Werth VP: Clinical signs associated with an increased risk of interstitial lung disease: a cohort study of 108 patients with dermatomyositis Br J Dermatol 176 (231-233): 2017.

Haber JS, Merola JF, Werth VP: Classifying Discoid Lupus Erythematosus: Background, Gaps, and Difficulties Int J Womens Derm 13 (S62-S66): 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects J Am Acad Dermatol 76 (11-16): 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients J Am Acad Dermatol 76 : 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health J Am Acad Dermatol 76 (1-9): 2017.

Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG: Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Infectious complications and vaccination recommendations J Am Acad Dermatol 76 (191-198): 2017.

Tiao J, Feng R, Bird S, Choi JK, MD, Dunham J, George M, Gonzalez-Rivera TC, Kaufman JL, Khan N, Luo JJ, Micheletti R, Payne AS, Price R, Quinn C, Rubin AI, Sreih AG, Thomas P, Okawa J, Werth VP: The Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) Among Dermatologists, Rheumatologists, and Neurologists Br J Dermatol 176 (423-4730): 2017.

The Myositis Association

Penn Dermatology website